Articles tagged "Liver transplantation"

2015 American Transplant Congress
Biliary Complication After Living Donor Liver Transplantation According to Biliary Reconstruction Methods
J. Lee,^1,2 J. Lee,^1,2 D. Han,^1,2 J. Lee,³ M. Ju,^1,2 M. Kim,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2
¹Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; ²The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea; ³Department of Surgery, CHA Bundang Medical Center, CHA University, Bundang, Korea.
BackgroundDespite improvement of operative techniques and long term outcomes, biliary complication remains as a severe obstacle in living donor liver transplantation.MethodsMedical records of 245 adult…
2015 American Transplant Congress
Racial Disparities in Living Donor Liver Transplantation
Y. Nobel,¹ K. Forde,² L. Wood,³ P. Yoo,⁴ P. Abt,³ D. Goldberg.²
¹Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ²Department of Medicine, University of Pennsylvania, Philadelphia, PA; ³Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA; ⁴Department of Surgery, Yale University School of Medicine, New Haven, CT.
Purpose: Living donor liver transplantation (LDLT) is an alternative to deceased donor transplantation (DDLT), and can mitigate the risk of dying while waiting for transplant.…
2015 American Transplant Congress
Preventing Cytomegalovirus Infection in Intermediate-High Risk Liver Transplant Recipients: Acyclovir Vs Valganciclovir
S. Dulanya, A. Anamisis, D. Tsapepas.
Department of Pharmacy, New York Presbyterian Hospital, New York City, NY.
Cytomegalovirus (CMV) is an opportunistic infection responsible for profound morbidity and mortality among solid organ transplant recipients. A donor and recipient's CMV IgG serostatus influences…
2015 American Transplant Congress
An Orchestrated Sequence of Innate and Adaptive Immune Responses Is Associated With Rejection After Pediatric Liver Transplantation
C. Falk,¹ I. Goldschmidt,² F. Mutschler,² C. Neudörfl,¹ J. Keil,¹ K. Daemen,¹ F. Lehner,³ R. Mikolajzcyk,⁴ A. Karch,⁴ U. Baumann.²
¹Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; ²Division of Pediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany; ³Department of Visceral General and Transplant Surgery, Hannover Medical School, Hannover, Germany; ⁴Department of Epidemiology, Helmholtz Center for Infection Research, HZI, Braunschweig, Braunschweig, Germany.
The concept of a coordinated immune response initiated by innate and sustained by adaptive immune cells and their soluble mediators is well established for infection…
2015 American Transplant Congress
Long-Term Outcome After Liver Transplantation for Unresectable Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment
S. Radunz,¹ T. Benkoe,¹ J. Best,² A. Bockisch,³ T. Lauenstein,⁴ H. Baba,⁵ A. Paul,¹ J. Treckmann.¹
¹General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; ²Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany; ³Nuclear Medicine, University Hospital Essen, Essen, Germany; ⁴Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany; ⁵Pathology and Neuropathology, University Hospital Essen, Essen, Germany.
Background: Liver transplantation remains the only curative treatment option for patients with unresectable hepatocellular carcinoma (HCC). Several bridging treatments are employed because the limited availability…
2015 American Transplant Congress
National Transplantation Pregnancy Registry: Cholestasis of Pregnancy in Liver Transplant Recipients
M. Moritz,^1,2 L. Coscia,² S. Constantinescu,³ D. Armenti.²
¹Lehigh Valley Health Network, Allentown; ²National Transplantation Pregnancy Registry, Gift of Life Institute, Philadelphia; ³Temple University School of Medicine, Philadelphia.
Cholestasis of pregnancy (COP) occurs in approximately 1% of pregnancies and is associated with increased risk of premature delivery. The purpose of this study was…
2015 American Transplant Congress
Identifying the “Operational Tolerant” Pediatric Liver Transplant Recipient by Cytometry by Time-of-Flight
A. Lau,^1,2 M. Vitalone,¹ K. Haas,³ T. Shawler,¹ C. Esquivel,¹ O. Martinez,¹ R. Castillo,³ S. Krams.¹
¹Surgery, Division of Abdominal Transplantation, Stanford University, Stanford, CA; ²Pediatrics, Div. Gastroenterology, Hepatology, and Nutrition, University of California, San Francisco, San Francisco, CA; ³Pediatrics, Div. Gastroenterology, Hepatology, and Nutrition, Stanford University, Stanford, CA.
Liver allografts are known to be well tolerated and indeed, some recipients of liver allografts retain stable graft function in the absence of immunosuppression. The…
2015 American Transplant Congress
Outcomes Between ABO-Incompatible Living Donor Liver Transplantation (LDLT) and ABO-Compatible LDLT: A Matched Study
J. Kim, S. Lee, W. Cho, J.-Y. Choi, G.-S. Choi, J. Park, C. Kwon, S. Kim, J.-W. Joh, S.-K. Lee.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Backgrounds: Reports from several experienced centers suggested that outcomes of an ABO-incompatible (ABOi) living donor liver transplantation (LDLT) after rituximab and reduction of ABO antibodies…
2015 American Transplant Congress
Pediatric Living Donor Liver Transplantation at KFSH&RC – Implementation of the Laparoscopic Retrieval in a High Volume Center
M. Boehnert, M. Shagrani, T. Al Goufi, D. Broering.
Organ Transplant Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Since the first successful pediatric liver transplantation was performed in 1967 the survival rate increased from 30 % to currently above 90 %. This is…
2015 American Transplant Congress
Renal Function Following Basiliximab Induction in Liver Transplant Recipients
J. Hagopian, T. Horwedel, L. Bowman, K. Collins, M. Doyle.
Washington University School of Medicine, St. Louis.
Purpose: Reports of the use of antibody induction to delay the start of calcineurin inhibitor therapy postoperatively in patients with renal insufficiency at the time…